Figure 3
Evaluation of both tumor volume and perfusion from B16F10-xenografted mice treated with mice anti-PD1 or PBS. (A) Evaluation of tumor perfusion through contrast enhanced ultrasonography (CEUS) at the beginning of treatment and one week after. (B) Tumor perfusion was measured by laser speckle contrast imaging at the beginning of treatment and one week after. Data are expressed as the mean ± SEM. Kruskal–Wallis test followed by a Dunn’s post hoc test (ns p>0.05).